Subscribe To
Biogen (biib) to end one of two parkinson's studies on biib122
Biogen BIIB announced that it is discontinuing one of the two studies on its and partner Denali Therapeutics' DNLI small ...
June 6, 2023, 11:59 am
Why is htg molecular diagnostics (htgm) stock down 42% today?
HTG molecular Diagnostics (NASDAQ: HTGM ) stock is falling on Tuesday after the company announced a Cha...
June 6, 2023, 9:17 am
Telesis bio to present at antibody engineering and therapeutics, europe 2023
Showcasing full suite of molecular biology workflow solutions for streamlining antibody discovery Showc...
June 6, 2023, 3:00 am
3 ugly stocks that actually hide beautiful potential
While the market theoretically prices in all publicly available information for all securities, the sheer volume of opportunities available breathe li...
June 5, 2023, 8:17 pm
Kalvista pharmaceuticals to present data at the 2023 meeting of the european academy of allergy and clinical immunology (eaaci)
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
June 2, 2023, 6:30 am
Tyra biosciences: early stage developer of novel fgfr3-selective molecules
TYRA has the first FGFR3 inhibitor in the clinic. The company has a large market cap for an early-stage company and a good deal of cash. They do not h...
June 1, 2023, 5:25 am
Willow biosciences signs msa with innovative biotech company to develop ingredients for age-related disease
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) told investors it has executed a Master Services Agreement (MSA) with an innovative biotech company to ...
May 31, 2023, 9:02 am
Immunic to participate in scientific and investor conferences in june
NEW YORK , May 30, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered,...
May 30, 2023, 6:30 am
Biomea: novel approach to diabetes and cancer
BMEA develops oral covalent small molecules for cancer and diabetes. Its lead asset is a menin inhibito...
May 28, 2023, 7:57 am
molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) — molecular Templates, Inc. (Nasdaq: MTEM, “...
May 26, 2023, 9:10 pm
molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting
AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- molecular Templates, Inc. (Nasdaq: MTEM, “...
May 26, 2023, 5:10 pm
molecular partners to present positive data from ongoing phase 1 trial of mp0317 (fap x cd40) monotherapy in patients with advanced solid tumors at the 2023 asco annual meeting
MP0317 demonstrates tumor-localized CD40 activation in tumor biopsies through target occupancy and immune cell activation...
May 25, 2023, 5:01 pm
Revolutionizing molecular biology: molecular grade plates market to witness exponential growth and reach us$ 427.1 million by 2033, persistence market research
Growing R&D and Increasing Investments in Healthcare will Propel the Overall molecular Grade Plates Mar...
May 25, 2023, 2:10 pm
Teknova to participate in upcoming investor conference
HOLLISTER, Calif., May 25, 2023 (GLOBE NEWSWIRE) — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for t...
May 25, 2023, 12:00 pm
Nautilus biotechnology to participate in upcoming june investor conferences
SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-...
May 24, 2023, 8:05 am
Dice therapeutics psoriasis treatment has blockbuster potential, analysts say
Canaccord Genuity (TSX:CF, LSE:CF) analysts have initiated coverage of DICE Therapeutics, Inc, a biopharmaceutical company focused on treating chronic...
May 23, 2023, 2:56 pm
Telesis bio to present at synbiobeta 2023
Highlighting application of the molecular Biology Workstation to accelerating vaccine and biologics dis...
May 23, 2023, 9:00 am
Kalvista pharmaceuticals to present at stifel 2023 tailoring genes: genetic medicines day virtual conference
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...
May 23, 2023, 6:30 am
Athira pharma appoints andrew gengos as chief financial officer and chief business officer
Veteran biopharmaceutical executive brings over 30 years of financial, corporate strategy, transactional and business development experience BOTHELL, ...
May 22, 2023, 11:00 am
Why is seqll (sql) stock up 43% today?
SeqLL (NASDAQ: SQL ) stock is on the rise Monday with heavy trading despite a lack of news from the mole...
May 22, 2023, 8:44 am